Expert in immunotechnologies since 1980, BIOTEM is a hybrid Contract Research Organization (CRO) and Contract Manufacturing Organization (CMO) which provides high added value services for the development / production of custom monoclonal antibodies and immunoassays (ELISA & LFIA).
Complying with ISO 9001:2008 Quality Standards, the company has been the privileged partner of more than 500 prestigious industrial and academic laboratories for their projects in fundamental research, development of improved diagnostics or generation of promising therapeutic tools.
Based on a high level of expertise and exclusive technologies, BIOTEM implements the most relevant strategies for each project according to the client’s specifications.
As a benefit, BIOTEM is keen to propose contracts with guaranteed results.
From the generation of original monoclonal antibodies ̶ by hybridoma and Phage Display technologies ̶ through their production, characterisation (affinity & specificity determination, sequencing, stability studies,…) and immunoassay developments, BIOTEM offers a wide range of customised services.